HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael Schumacher Selected Research

Progesterone Congeners

10/2021Sex differences in the cerebroprotection by Nestorone intranasal delivery following stroke in mice.
1/2021Nestorone® , a 19nor-progesterone derivative boosts remyelination in an animal model of demyelination.
1/2015Progesterone and nestorone promote myelin regeneration in chronic demyelinating lesions of corpus callosum and cerebral cortex.
8/2012Progesterone receptors: a key for neuroprotection in experimental stroke.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael Schumacher Research Topics

Disease

13Spinal Cord Injuries (Spinal Cord Injury)
01/2021 - 03/2002
12Demyelinating Diseases (Demyelinating Disease)
01/2021 - 07/2009
10Stroke (Strokes)
10/2021 - 08/2012
10Neurodegenerative Diseases (Neurodegenerative Disease)
03/2020 - 06/2002
7Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2022 - 06/2002
7Multiple Sclerosis
01/2021 - 11/2009
7Traumatic Brain Injuries (Traumatic Brain Injury)
01/2021 - 06/2005
7Ischemic Stroke
01/2020 - 10/2007
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 11/2020
6Gliosis
01/2022 - 12/2002
5Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
04/2020 - 01/2011
5Inflammation (Inflammations)
11/2015 - 10/2007
4Edema (Dropsy)
01/2022 - 05/2007
4Neoplasms (Cancer)
01/2021 - 06/2007
3Atrophy
05/2021 - 02/2007
3Nervous System Diseases (Neurological Disorders)
01/2021 - 02/2007
3Mitochondrial Diseases (Mitochondrial Disease)
05/2020 - 03/2016
3Facial Paralysis (Facial Palsy)
01/2020 - 01/2014
3Infarction (Infarctions)
01/2019 - 10/2015
3Brain Injuries (Brain Injury)
01/2019 - 07/2009
3Pre-Eclampsia (Preeclampsia)
01/2018 - 11/2010
3Ischemia
03/2016 - 12/2002
3Alzheimer Disease (Alzheimer's Disease)
11/2009 - 11/2002
2Ulcer
01/2022 - 01/2013
2Hypertension (High Blood Pressure)
11/2021 - 01/2021
2Disease Progression
05/2021 - 01/2021
2Chronic Disease (Chronic Diseases)
08/2020 - 01/2019
2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2020 - 11/2017
2Hypersensitivity (Allergy)
01/2018 - 01/2010
2Motor Neuron Disease (Primary Lateral Sclerosis)
12/2013 - 12/2002
2Peripheral Nervous System Diseases (PNS Diseases)
07/2009 - 06/2002
1Acute Pain
05/2022
1Sclerosis
01/2022
1Virus Diseases (Viral Diseases)
01/2022
1Major Depressive Disorder (Major Depressive Disorders)
01/2022
1Postpartum Depression (Post-Natal Depression)
01/2022
1Neuroinflammatory Diseases
01/2022
1Fatigue
01/2021
1Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy)
01/2021
1Abdominal Pain (Pain, Abdominal)
01/2021
1Asthenia
01/2021
1Brain Neoplasms (Brain Tumor)
01/2021
1Neoplasm Metastasis (Metastasis)
01/2021
1Lung Neoplasms (Lung Cancer)
11/2020

Drug/Important Bio-Agent (IBA)

34ProgesteroneFDA LinkGeneric
01/2022 - 11/2002
8SteroidsIBA
05/2021 - 02/2007
7Neuroprotective AgentsIBA
01/2022 - 06/2005
6EnzymesIBA
01/2022 - 05/2009
6Progesterone Receptors (Progesterone Receptor)IBA
01/2021 - 11/2014
5NeurosteroidsIBA
01/2022 - 11/2002
5LigandsIBA
01/2022 - 06/2002
5Pharmaceutical PreparationsIBA
10/2021 - 08/2007
5Testosterone (Sustanon)FDA Link
05/2021 - 11/2009
5Lysophosphatidylcholines (Lysophosphatidylcholine)IBA
04/2020 - 10/2011
5Messenger RNA (mRNA)IBA
01/2017 - 02/2005
5Proteins (Proteins, Gene)FDA Link
12/2010 - 03/2002
4ST 1435IBA
10/2021 - 10/2011
4Progesterone CongenersIBA
10/2021 - 08/2012
4Progestins (Progestagens)IBA
01/2021 - 06/2007
4CuprizoneIBA
01/2021 - 01/2013
4Hormones (Hormone)IBA
05/2019 - 12/2002
4Estrogens (Estrogen)FDA Link
01/2017 - 06/2007
3Pregnanolone (Allopregnanolone)IBA
01/2022 - 11/2002
3OxysterolsIBA
06/2011 - 05/2009
3Adenosine Triphosphatases (ATPase)IBA
07/2009 - 03/2002
3Brain-Derived Neurotrophic Factor (BDNF)IBA
07/2009 - 02/2005
3Choline O-Acetyltransferase (Choline Acetyltransferase)IBA
07/2009 - 03/2002
2Opioid Analgesics (Opioids)IBA
05/2022 - 05/2020
2AndrogensIBA
05/2021 - 01/2013
2Glucose (Dextrose)FDA LinkGeneric
01/2019 - 01/2016
2Biomarkers (Surrogate Marker)IBA
01/2018 - 12/2010
2Aromatase (CYP19)IBA
01/2018 - 11/2010
2Glial Fibrillary Acidic ProteinIBA
12/2016 - 12/2002
2Androgen Receptors (Androgen Receptor)IBA
01/2014 - 01/2013
2Analgesics (Analgesic Drugs)IBA
01/2014 - 09/2011
2Therapeutic UsesIBA
12/2013 - 01/2013
2CholesterolIBA
06/2011 - 11/2009
2Secretory Phospholipases A2IBA
11/2009 - 05/2009
2Transcription Factors (Transcription Factor)IBA
07/2009 - 06/2009
2Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
07/2009 - 02/2009
2Dehydroepiandrosterone (DHEA)IBA
04/2003 - 11/2002
1zuranoloneIBA
01/2022
1CreatinineIBA
01/2022
1Alanine Transaminase (SGPT)IBA
01/2022
1brexanoloneIBA
01/2022
1capmatinibIBA
01/2022
1AfatinibIBA
01/2021
1Small Interfering RNA (siRNA)IBA
01/2021
1Phosphotransferases (Kinase)IBA
01/2021
1ErbB Receptors (EGF Receptor)IBA
01/2021
1selpercatinibIBA
01/2021
1lorlatinibIBA
11/2020
1Anaplastic Lymphoma KinaseIBA
11/2020
1Tyrosine Kinase InhibitorsIBA
11/2020
1Morphine (MS Contin)FDA LinkGeneric
05/2020

Therapy/Procedure

6Therapeutics
10/2021 - 01/2013
2Intranasal Administration
01/2020 - 01/2019
1Transplantation
01/2022
1Ambulatory Care (Outpatient Care)
11/2021
1Homeopathy
12/2020